This inventor holds 2 USPTO granted patents. Top assignees: Pharmachim, S O 'Pharmachim'. Active years: 1990-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1991
Title: Maria G Todorova: Innovator in Pharmaceutical Science
Introduction
Maria G Todorova is a prominent inventor based in Sofia, Bulgaria. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drugs. With a total of 2 patents, her work focuses on addressing critical health issues through her inventions.
Latest Patents
Maria's latest patents include an antihypoxic drug and a method for treating glaucoma. The antihypoxic drug is designed to provide both verebroprotective and hepatoprotective effects. It contains piracetam and orotic acid or their pharmaceutically tolerable salts in a specific weight ratio. This combined drug is administered for the treatment of acute and chronic diseases, as well as exogenic intoxications. The drug can be taken orally or parenterally, depending on the severity of the condition.
Her second patent involves an antiglaucoma composition that utilizes a specific chemical compound to treat glaucoma. This composition is administered as an ophthalmic solution, with a recommended dosage of 2 to 3 drops two to four times daily.
Career Highlights
Throughout her career, Maria has worked with notable companies such as Pharmachim and S O Pharmachim. Her experience in these organizations has contributed to her expertise in pharmaceutical development and innovation.
Collaborations
Maria has collaborated with several professionals in her field, including Marko T Markov and Chavdar B Ivanov. These partnerships have enhanced her research and development efforts, leading to successful innovations.
Conclusion
Maria G Todorova is a remarkable inventor whose work in pharmaceutical science has the potential to improve health outcomes. Her innovative patents reflect her dedication to addressing significant medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile